Joseph M. Fitzgerald

2020

In 2020, Joseph M. Fitzgerald earned a total compensation of $4.6M as Executive Vice President and President, Interventional Cardiology at Boston Scientific, a 14% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$59,902
Non-Equity Incentive Plan$414,010
Option Awards$1,624,991
Salary$568,679
Stock Awards$1,907,997
Other$22,754
Total$4,598,333

Fitzgerald received $1.9M in stock awards, accounting for 41% of the total pay in 2020.

Fitzgerald also received $59.9K of change in pension value and nonqualified deferred compensation earnings, $414K in non-equity incentive plan, $1.6M in option awards, $568.7K in salary and $22.8K in other compensation.

Rankings

In 2020, Joseph M. Fitzgerald's compensation ranked 2,437th out of 13,090 executives tracked by ExecPay. In other words, Fitzgerald earned more than 81.4% of executives.

ClassificationRankingPercentile
All
2,437
out of 13,090
81st
Division
Manufacturing
933
out of 5,617
83rd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
107
out of 799
87th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
59
out of 495
88th
Industry
Surgical and Medical Instruments and Apparatus
39
out of 313
88th

Pay ratio

Joseph M. Fitzgerald's Pay$4,598,333
Median Employee's Pay$59,332
Pay Ratio

78

to 1

In 2020, the annual total compensation of Joseph M. Fitzgerald was $4,598,333.

The annual total compensation of the median employee at Boston Scientific was $59,332.

The ratio of Joseph M. Fitzgerald's pay to the pay of median employee was therefore 78 to one.

Source: SEC filing on March 24, 2021.

Fitzgerald's colleagues

We found four more compensation records of executives who worked with Joseph M. Fitzgerald at Boston Scientific in 2020.

2020

Michael Mahoney

Boston Scientific

Chief Executive Officer

2020

Daniel Brennan

Boston Scientific

Chief Financial Officer

2020

Edward Mackey

Boston Scientific

Executive Vice President, Operations

2020

Jeffrey Mirviss

Boston Scientific

Executive Vice President and President, Peripheral Interventions

News

You may also like